Accounting for time: Insights from a life-table analysis of the efficacy of medical abortion

American Journal of Obstetrics and Gynecology

Volumn 191, Issue 6, 2004, Pages 1928-1933

  Hedley, Allison ^a   Ellertson, Charlotte ^b   Trussell, James ^a   Turner, Abigail Norris ^c   Aubény, Elisabeth ^d   Coyaji, Kurus ^e   Ngoc, Nguyen Thi Nhu ^f   Winikoff, Beverly ^g  

^a PRINCETON UNIVERSITY   (United States)

^b IBIS REPRODUCTIVE HEALTH   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d HÔPITAL BROUSSAIS   (France)

^e KEM HOSPITAL   (India)

^f Vietnam   (Viet Nam)

^g GYNUITY HEALTH PROJECTS   (United States)

Author keywords

Life table analysis; Medical abortion

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ABORTION; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; HUMAN; LIFE TABLE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROBABILITY; STATISTICAL ANALYSIS; VACUUM ASPIRATION;

ABORTIFACIENT AGENTS; ABORTION, THERAPEUTIC; ADOLESCENT; ADULT; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INDIA; MIDDLE AGED; MIFEPRISTONE; MISOPROSTOL; PREGNANCY; PREGNANCY OUTCOME; PROBABILITY; RISK ASSESSMENT; STATISTICS; TREATMENT OUTCOME;

EID: 10044254182     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.06.108     Document Type: Article

References (12)

1. B. Winikoff, C. Ellertson, and S. Clark Analysis of failure in medical abortion Contraception 54 1996 323 327
2. J. Trussell, and C. Ellertson Estimating the efficacy of medical abortion Contraception 60 1999 119 135
3. E. Newhall, and B. Winikoff Abortion with mifepristone and misoprostol: Regimens, efficacy, acceptability, and future directions Am J Obstet Gynecol 183 2000 S44 S53
4. N. Ngoc, B. Winikoff, S. Clark, C. Ellertson, K. Am, and D. Hieu Safety, efficacy and acceptability of mifepristone-misoprostol medical abortion in Vietnam Int Fam Plann Perspect 25 1999 10 14 33
5. I. Spitz, C. Bardin, L. Benton, and A. Robbins Early pregnancy termination with mifepristone and misoprostol in the United States N Engl J Med 338 1998 1241 1247
6. J.G. Kahn, B.J. Becker, L. MacIsaa, J.K. Armory, J. Neuhaus, and I. Olkin The efficacy of medical abortion: a meta-analysis Contraception 61 2000 29 40
7. E. Aubény, R. Peyron, C. Turpin, M. Renault, V. Targosz, and L. Silvestre Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol [corrected] Int J Fertil Menopausal Stud 40 2 Suppl 1995 85 91
8. B. Winikoff, I. Sivin, K. Coyaji, E. Cabezas, X. Bilian, and G. Sujuan Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion Am J Obstet Gynecol 176 1997 431 437
9. K. Coyaji, B. Elul, U. Krishna, S. Otiv, S. Ambardekar, and A. Bopardikar Mifepristone abortion outside the urban research hospital setting in India Lancet 357 2001 120 122
10. R. Peyron, A. Ulmann, and E. Baulieu [Mifepristone (RU 486) in 1995: present status, prospectives] (in French) Presse Med 24 1995 295 298
11. K. Namboodiri, and C. Suchindran Life table techniques and their applications. studies in population 1987 Academic Press Orlando (FL)
12. D. Urquhart, A. Templeton, F. Shinewi, M. Chapman, K. Hawkins, and J. McGarry The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK Multicentre Study - final results Contraception 55 1997 1 5